Table 2 Cox proportional hazards regression analyses for the association between baPWV-based VA and the risk of cardiovascular events
Outcomes | VA Categories | Event n (%) | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|---|
HR (95%CI) | P-value | HR (95%CI) | P-value | ||||
MACE | ∆-age | 173(3) | 1.05(1.01–1.09) | 0.025 | 1.04(1.00–1.09) | 0.044 | |
SUPERNOVA | 14(2.4) | 0.90(0.52–1.56) | 0.704 | 0.84(0.48–1.47) | 0.536 | ||
Normal VA | 123(2.7) | reference | - | reference | - | ||
EVA | 36(6.3) | 1.95(1.34–2.84) | <0.001 | 1.84(1.25–2.73) | 0.002 | ||
CVD mortality | ∆-age | 21(0.4) | 1.10(0.98–1.22) | 0.104 | 1.08(0.96–1.21) | 0.193 | |
SUPERNOVA | 0(0.0) | - | - | - | - | ||
Normal VA | 16(0.3) | reference | - | reference | - | ||
EVA | 5(0.9) | 1.87(0.68–5.15) | 0.226 | 1.64(0.56–4.77) | 0.364 | ||
AMI | ∆-age | 35(0.6) | 1.01(0.93–1.10) | 0.820 | 1.01(0.92–1.11) | 0.806 | |
SUPERNOVA | 2(0.3) | 0.60(0.14–2.53) | 0.484 | 0.54(0.12–2.31) | 0.404 | ||
Normal VA | 27(0.6) | reference | - | reference | - | ||
EVA | 6(1.0) | 1.50(0.61–3.66) | 0.374 | 1.44(0.57–3.64) | 0.443 | ||
Stroke | ∆-age | 130(2.3) | 1.05(1.00–1.10) | 0.034 | 1.05(1.00–1.10) | 0.044 | |
SUPERNOVA | 12(2.1) | 1.07(0.59–1.96) | 0.822 | 0.99(0.54–1.85) | 0.987 | ||
Normal VA | 89(1.9) | reference | - | reference | - | ||
EVA | 29(5.1) | 2.14(1.40–3.27) | <0.001 | 2.08(1.33–3.24) | 0.001 | ||
